RetractionWatch-Flagged.pdf

Recommendations

Relevance analysis suggests additional references and improvement opportunities. Use [R#] markers to jump to the full reference list below.

This 2023 review on COVID-19 and kidney dysfunction has strong foundational citations but needs strengthening in three areas. Priority 1: Add the missing highly connected paper on early Wuhan clinical characteristics [R33] that would strengthen the epidemiological background. Priority 2: Add recent 2023 bibliographic coupling papers on AKI mechanisms and clinical manifestations [R49, R52, R54] to enhance currency and depth. Priority 3: Justify or reconsider six tangential citations [R26-R31] that cover topics only indirectly related to the main focus on COVID-19 kidney pathology.

Top priorities

1. Priority 1: Add citation to the foundational early clinical study by Huang et al. describing the first 41 confirmed COVID-19 patients from Wuhan. - Add after the first epidemiological statement in the Introduction where severity rates and organ involvement are discussed.

   Add

   This seminal paper established the original clinical characterization of COVID-19 and is heavily cited in the field, providing essential context for understanding disease manifestations including organ involvement.

   According to epidemiological data, the severity of the illness from coronavirus disease 2019 (COVID-19) is as high as 25%, and even though the lungs are the main organs affected, the kidney is among the different organs that are significantly affected with the SARS-CoV-2 infection

   Supporting refs: [R33]

2. Priority 2: Add citation support for the claim that AKI is more frequent in critically ill COVID-19 patients - In the first paragraph after 'AKI is more frequent in critically ill COVID-19 patients'

   Justify

   The opening sentence makes a strong epidemiological claim without verifiable support from the reference list

   AKI is more frequent in critically ill COVID-19 patients, according to recent data

   Supporting refs: [R16], [R19]

3. Priority 3: Add epidemiological data on AKI incidence and mortality in COVID-19 patients - After the sentence describing pathophysiological mechanisms

   Justify

   The opening paragraph makes broad claims about pathophysiology without quantifying the clinical burden of AKI in COVID-19 patients

   Cytokine storm, hypoxemia, direct viral invasion via angiotensin-converting enzyme 2 and cathepsin L, electrolyte imbalance, and fever are among the pathophysiological mechanisms

   Supporting refs: [R16], [R65], [R8]

4. Priority 4: Clarify the distinction between direct tubular injury and indirect (ischemic/hemodynamic) injury - In the ACE2 Pathway subsection

   Reconsider

   The section mixes direct viral cytotoxicity with indirect injury mechanisms without clearly differentiating them

   COVID-19-induced renal impairment may result from the synergistic interaction of immunological responses like cytokine storm, macrophage activation syndrome, and lymphopenia with virus-induced direct cytotropic effects

   Supporting refs: [R57]

5. Priority 5: Add a framing sentence at the opening to establish the clinical significance of kidney involvement in COVID-19 - After the first sentence about Wuhan hospitals

   Strengthen

   The section jumps directly into clinical data without explaining why renal complications matter for patient outcomes

   In December 2019, adults in Wuhan began presenting to local hospitals

   Supporting refs: [R23]

Other changes by section

Derived from citation-coupled works that cite many of your references.

Complete reference list

All deep-analysis references, alphabetized by author. Use the filter to show only references from a given group.

1. [R143] Agís‐Balboa, R. C. & Fischer, A. (2013). Generating new neurons to circumvent your fears: the role of IGF signaling.
   Source: Cellular and Molecular Life Sciences
   DOI: 10.1007/s00018-013-1316-2
2. [R60] Ahmadian, E., Khatibi, S. M. H., Soofiyani, S. R., Abediazar, S., Shoja, M. M., et al. (2020). Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms. Reviews in Medical Virology, 31(3), e2176.
   Source: Reviews in Medical Virology
   DOI: 10.1002/rmv.2176 Open PDF
   Already cited
3. [R19] Anandh, U., Noorin, A., Kazmi, S. K. S., Bannur, S., Shah, S. S. A., et al. (2022). Acute kidney injury in critically ill COVID-19 infected patients requiring dialysis: experience from India and Pakistan. BMC Nephrology, 23(1), 308.
   Source: BMC Nephrology
   DOI: 10.1186/s12882-022-02931-3 Open PDF
   Already cited
4. [R196] Anavekar, N. S., McMurray, J. J., Velazquez, E. J., Solomon, S. D., Køber, L., et al. (2004). Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction.
   Source: New England Journal of Medicine
   DOI: 10.1056/nejmoa041365 Open PDF
5. [R169] Angus, D. C., Linde‐Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J. A., & Pinsky, M. R. (2001). Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care.
   Source: Critical Care Medicine
   DOI: 10.1097/00003246-200107000-00002
6. [R50] Aref, A., Valizadeh, Z., Sakiani, M., Maleknia, M., Arani, Z. S., & Kazemi, H. (2023). Acute Renal Failure in a Patient with Coronavirus: A Case Report of a Rarely-Seen Presentation.
   Source: Gene Cell and Tissue
   DOI: 10.5812/gct-135159 Open PDF
7. [R140] Assiri, A. M., Al‐Tawfiq, J. A., Al-Rabeeah, A. A., Alrabiah, F., Al-Hajjar, S., et al. (2013). Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.
   Source: The Lancet Infectious Diseases
   DOI: 10.1016/s1473-3099(13)70204-4 Open PDF
8. [R111] Basu, R. K. & Wheeler, D. S. (2013). Kidney–lung cross-talk and acute kidney injury.
   Source: Pediatric Nephrology
   DOI: 10.1007/s00467-012-2386-3 Open PDF
9. [R16] Bayrakçı, N., Özkan, G., Şakacı, M., Sedef, S., Erdem, İ., et al. (2022). The incidence of acute kidney injury and its association with mortality in patients diagnosed with<scp>COVID</scp>‐19 followed up in intensive care unit. Therapeutic Apheresis and Dialysis, 26(5), 889–896.
   Source: Therapeutic Apheresis and Dialysis
   DOI: 10.1111/1744-9987.13790
   Already cited
10. [R32] Birkelo, B. C., Parr, S. K., Perkins, A. M., Greevy, R. A., Hung, A. M., et al. (2021). Comparison of COVID-19 versus influenza on the incidence, features, and recovery from acute kidney injury in hospitalized United States Veterans. Kidney International, 100(4), 894–905.
    Source: Kidney International
    DOI: 10.1016/j.kint.2021.05.029 Open PDF
    Already cited
11. [R122] Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., et al. (2013). Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation.
    Source: Cellular Physiology and Biochemistry
    DOI: 10.1159/000350110 Open PDF
12. [R72] Brogan, M. & Ross, M. J. (2021). The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit. ˜The œNephron journals/Nephron journals, 146(1), 67–71.
    Source: ˜The œNephron journals/Nephron journals
    DOI: 10.1159/000519530 Open PDF
    Already cited
13. [R188] Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Störmer, J., & Hansen, J. (2009). Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study.
    Source: Journal of Thrombosis and Haemostasis
    DOI: 10.1111/j.1538-7836.2009.03498.x
14. [R139] Buchert, R. (2005). Adjusted Scaling of FDG Positron Emission Tomography Images for Statistical Evaluation in Patients With Suspected Alzheimer's Disease.
    Source: Journal of Neuroimaging
    DOI: 10.1177/1051228405280169
15. [R180] Bäder, M. (2012). ACE2, angiotensin-(1–7), and Mas: the other side of the coin.
    Source: Pflügers Archiv - European Journal of Physiology
    DOI: 10.1007/s00424-012-1120-0
16. [R51] Bălan, C., Ciuhodaru, T., & Bubenek-Turconi, Ş. (2023). Kidney Injury in Critically Ill Patients with COVID-19 – From Pathophysiological Mechanisms to a Personalized Therapeutic Model.
    Source: ˜The œJournal of Critical Care Medicine
    DOI: 10.2478/jccm-2023-0023 Open PDF
17. [R74] Carsana, L., Sonzogni, A., Nasr, A., Rossi, R., Pellegrinelli, A., et al. (2020). Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases, 20(10), 1135–1140.
    Source: The Lancet Infectious Diseases
    DOI: 10.1016/s1473-3099(20)30434-5 Open PDF
    Already cited
18. [R86] Cazzola, M., Bergamaschi, G., Tonon, L., Arbustini, E., Grasso, M., et al. (1997). Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA.
    Source: Blood
    DOI: 10.1182/blood.v90.2.814 Open PDF
19. [R11] Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C. (2020). The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovascular Research, 116(6), 1097–1100.
    Source: Cardiovascular Research
    DOI: 10.1093/cvr/cvaa078 Open PDF
    Already cited
20. [R7] Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513.
    Source: The Lancet
    DOI: 10.1016/s0140-6736(20)30211-7 Open PDF
    Already cited
21. [R171] Chen, Y., Rubin, P., Williams, J. S., Hernady, E., Smudzin, T., & Okunieff, P. (2001). Circulating IL-6 as a predictor of radiation pneumonitis.
    Source: International Journal of Radiation Oncology*Biology*Physics
    DOI: 10.1016/s0360-3016(00)01445-0
22. [R186] Cheng, S., Wong, C. W., Tsang, J. S., & Wong, K. (2004). Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS).
    Source: Psychological Medicine
    DOI: 10.1017/s0033291704002272
23. [R128] Chu, K. H., Tsang, W. K., Tang, C., Lam, M. F., Lai, F. M., et al. (2005). Acute renal impairment in coronavirus-associated severe acute respiratory syndrome.
    Source: Kidney International
    DOI: 10.1111/j.1523-1755.2005.67130.x Open PDF
24. [R155] Chu, S., Becker, R. C., Berger, P. B., Bhatt, D. L., Eikelboom, J. W., et al. (2009). Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis.
    Source: Journal of Thrombosis and Haemostasis
    DOI: 10.1111/j.1538-7836.2009.03584.x Open PDF
25. [R158] Coca, S. G., Yusuf, B., Shlipak, M. G., Garg, A. X., & Parikh, C. R. (2009). Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis.
    Source: American Journal of Kidney Diseases
    DOI: 10.1053/j.ajkd.2008.11.034
26. [R152] Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., et al. (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function.
    Source: Nature
    DOI: 10.1038/nature00786
27. [R181] Croft, M., So, T., Duan, W., & Soroosh, P. (2009). The significance of OX40 and OX40L to T‐cell biology and immune disease.
    Source: Immunological Reviews
    DOI: 10.1111/j.1600-065x.2009.00766.x
28. [R98] Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., et al. (2015). The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.
    Source: Immunity
    DOI: 10.1016/j.immuni.2015.08.010 Open PDF
29. [R172] Dalrymple, L. S., Mu, Y., Romano, P. S., Nguyen, D. V., Chertow, G. M., et al. (2015). Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis.
    Source: American Journal of Kidney Diseases
    DOI: 10.1053/j.ajkd.2014.11.030
30. [R12] Datta, S., Talwar, A., & Lee, J. T. (2020). A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection. JAMA, 324(22), 2251.
    Source: JAMA
    DOI: 10.1001/jama.2020.22717
    Already cited
31. [R124] Davies, R. & Choy, E. (2014). Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis.
    Source: Seminars in Immunology
    DOI: 10.1016/j.smim.2013.12.002
32. [R173] Delahanty, D. L., Dougall, A. L., Craig, K. J., Jenkins, F. J., & Baum, A. (1997). Chronic Stress and Natural Killer Cell Activity After Exposure to Traumatic Death.
    Source: Psychosomatic Medicine
    DOI: 10.1097/00006842-199709000-00002
33. [R190] Desai, T. R., Leeper, N. J., Hynes, K. L., & Gewertz, B. L. (2002). Interleukin-6 Causes Endothelial Barrier Dysfunction via the Protein Kinase C Pathway.
    Source: Journal of Surgical Research
    DOI: 10.1006/jsre.2002.6415
34. [R115] Devinsky, O., Vezzani, A., Najjar, S., Lanerolle, N. C. D., & Rogawski, M. A. (2013). Glia and epilepsy: excitability and inflammation.
    Source: Trends in Neurosciences
    DOI: 10.1016/j.tins.2012.11.008
35. [R40] Dikamu, M., Syraji, Y., PR, J., Gobikanila, K., Raza, A., & Ezez, D. (2025). Nanotechnology in COVID-19 prevention, diagnosis, and treatment: a comprehensive review.
    Source: Discover Nano
    DOI: 10.1186/s11671-025-04412-6
36. [R132] Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., et al. (2000). A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9.
    Source: Circulation Research
    DOI: 10.1161/01.res.87.5.e1 Open PDF
37. [R94] Dryden, M., Baguneid, M., Eckmann, C., Corman, S., Stephens, J., et al. (2015). Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections.
    Source: Clinical Microbiology and Infection
    DOI: 10.1016/j.cmi.2015.03.024 Open PDF
38. [R76] Du, F., Liu, B., & Zhang, Y. (2020). COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness. Journal of Thrombosis and Thrombolysis, 51(2), 313–329.
    Source: Journal of Thrombosis and Thrombolysis
    DOI: 10.1007/s11239-020-02224-2 Open PDF
    Already cited
39. [R84] Eklund, C. (2009). Chapter 5 Proinflammatory cytokines in CRP baseline regulation.
    Source: Advances in clinical chemistry
    DOI: 10.1016/s0065-2423(09)48005-3
40. [R49] Eldaboosy, S. A., Awad, A., Farouk, A., Mahdy, W., Abdelsalam, E. M. N., et al. (2023). Acute kidney injury in Coronavirus disease-19 related pneumonia in the intensive care unit: a retrospective multicenter study, Saudi Arabia.
    Source: Multidisciplinary Respiratory Medicine
    DOI: 10.4081/mrm.2023.895 Open PDF
41. [R110] Erbaş, G., Oktar, S. Ö., Kılıç, K., Şen, İ., Budakoğlu, I. İ., & Araç, M. (2011). Unenhanced urinary CT: Value of parenchymal attenuation measurements in differentiating acute vs. chronic renal obstruction.
    Source: European Journal of Radiology
    DOI: 10.1016/j.ejrad.2011.02.029
42. [R93] Falk, R. J. & Jennette, J. C. (1997). ANCA small-vessel vasculitis.
    Source: Journal of the American Society of Nephrology
    DOI: 10.1681/asn.v82314
43. [R2] Faour, W. H., Choaib, A., Issa, E., Choueiry, F. E., Shbaklo, K., et al. (2021). Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflammation Research, 71(1), 39–56.
    Source: Inflammation Research
    DOI: 10.1007/s00011-021-01520-8 Open PDF
    Already cited
44. [R61] Farouk, S., Fiaccadori, E., Cravedi, P., & Campbell, K. N. (2020). COVID-19 and the kidney: what we think we know so far and what we don’t. Journal of Nephrology, 33(6), 1213–1218.
    Source: Journal of Nephrology
    DOI: 10.1007/s40620-020-00789-y Open PDF
    Already cited
45. [R106] Fazzini, E., Fleming, J. O., & Fahn, S. (1992). Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease.
    Source: Movement Disorders
    DOI: 10.1002/mds.870070210 Open PDF
46. [R91] Felicetti, P., Trotta, F., Bonetto, C., Santuccio, C., Pernus, Y. B., et al. (2015). Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
    Source: Vaccine
    DOI: 10.1016/j.vaccine.2015.09.027
47. [R126] Feng, Y., Nikolić, N., Bakke, S. S., Boekschoten, M. V., Kersten, S., et al. (2013). PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.
    Source: Archives of Physiology and Biochemistry
    DOI: 10.3109/13813455.2013.829105
48. [R157] Ferrario, C. M., Jessup, J. A., Chappell, M. C., Averill, D. B., Brosnihan, K. B., et al. (2005). Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2.
    Source: Circulation
    DOI: 10.1161/circulationaha.104.510461
49. [R27] Fischetti, F. & Tedesco, F. (2006). Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. Autoimmunity, 39(5), 417–428.
    Source: Autoimmunity
    DOI: 10.1080/08916930600739712
    Already cited
50. [R125] Fleming, J. O., Stohlman, S. A., & Weiner, L. P. (1982). Coronaviruses and Multiple Sclerosis.
    Source: Archives of Neurology
    DOI: 10.1001/archneur.1982.00510190073030
51. [R167] Flevaris, P., Li, Z., Zhang, G., Zheng, Y., Liu, J., & Du, X. (2008). Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK–dependent integrin outside-in retractile signaling pathway.
    Source: Blood
    DOI: 10.1182/blood-2008-05-155978 Open PDF
52. [R92] Force, A. D. T. (2012). Acute Respiratory Distress Syndrome.
    Source: JAMA
    DOI: 10.1001/jama.2012.5669
53. [R58] Gasparini, G., Canepa, P., Verdiani, S., Carmisciano, L., Cozzani, E., et al. (2021). A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients. International Journal of Immunopathology and Pharmacology, 35, 20587384211042115.
    Source: International Journal of Immunopathology and Pharmacology
    DOI: 10.1177/20587384211042115
    Already cited
54. [R29] Gautam, R. & Sharma, M. (2020). 2019-nCoV pandemic: A disruptive and stressful atmosphere for Indian academic fraternity. Brain Behavior and Immunity, 88, 948–949.
    Source: Brain Behavior and Immunity
    DOI: 10.1016/j.bbi.2020.04.025
    Already cited
55. [R97] Georgiades, C., Moore, C. J., & Smith, D. P. (2001). Differences of Renal Parenchymal Attenuation for Acutely Obstructed and Unobstructed Kidneys on Unenhanced Helical CT.
    Source: American Journal of Roentgenology
    DOI: 10.2214/ajr.176.4.1760965
56. [R135] Glowacka, I., Bertram, S., Herzog, P., Pfefferle, S., Steffen, I., et al. (2009). Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63.
    Source: Journal of Virology
    DOI: 10.1128/jvi.01248-09
57. [R164] Goldman, S. M., Faintuch, S., Ajzen, S., Christofalo, D. M. J., Araújo, M. P., et al. (2004). Diagnostic Value of Attenuation Measurements of the Kidney on Unenhanced Helical CT of Obstructive Ureterolithiasis.
    Source: American Journal of Roentgenology
    DOI: 10.2214/ajr.182.5.1821251
58. [R136] Guaraldi, F. & Salvatori, R. (2012). Cushing Syndrome: Maybe Not So Uncommon of an Endocrine Disease.
    Source: The Journal of the American Board of Family Medicine
    DOI: 10.3122/jabfm.2012.02.110227 Open PDF
59. [R184] Gurley, S. B., Allred, A. J., Le, T. H., Griffiths, R., Mao, L., et al. (2006). Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.
    Source: Journal of Clinical Investigation
    DOI: 10.1172/jci16980 Open PDF
60. [R133] Gómez, H., İnce, C., Backer, D. D., Pickkers, P., Payen, D., et al. (2013). A Unified Theory of Sepsis-Induced Acute Kidney Injury.
    Source: Shock
    DOI: 10.1097/shk.0000000000000052
61. [R57] Hachimi, A., El‐Mansoury, B., & Merzouki, M. (2025). Incidence, pathophysiology, risk factors, histopathology, and outcomes of COVID-19-induced acute kidney injury: A narrative review.
    Source: Microbial Pathogenesis
    DOI: 10.1016/j.micpath.2025.107360
62. [R77] Hamed, M. A. (2021). COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk. Coronaviruses, 2(10).
    Source: Coronaviruses
    DOI: 10.2174/2666796702666210202124650
    Already cited
63. [R45] Hamrouni, K., Ferlazo, A., Essid, M., Zghab, I., Alharbi, A. S., et al. (2026). Novel heteroaromatic species for sensitive electrochemical detection of dopamine and tyrosine.
    Source: Journal of Materials Science Materials in Electronics
    DOI: 10.1007/s10854-026-16624-2
64. [R81] Hanna, N. H., Robinson, A., Temin, S., Baker, S., Brahmer, J. R., et al. (2021). Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Journal of Clinical Oncology, 39(9), 1040–1091.
    Source: Journal of Clinical Oncology
    DOI: 10.1200/jco.20.03570
    Already cited
65. [R149] Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., et al. (2012). ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
    Source: Nature
    DOI: 10.1038/nature11228 Open PDF
66. [R88] Heemskerk, J. W. M., Mattheij, N. J., & Cosemans, J. M. (2012). Platelet‐based coagulation: different populations, different functions.
    Source: Journal of Thrombosis and Haemostasis
    DOI: 10.1111/jth.12045 Open PDF
67. [R118] Heemskerk, S., Masereeuw, R., Moesker, O., Bouw, M. P. W. J. M., Hoeven, J. G. V. D., et al. (2009). Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients*.
    Source: Critical Care Medicine
    DOI: 10.1097/ccm.0b013e31819598af
68. [R131] Heurich, A., Hofmann-Winkler, H., Gierer, S., Liepold, T., Jahn, O., & Pöhlmann, S. (2013). TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein.
    Source: Journal of Virology
    DOI: 10.1128/jvi.02202-13
69. [R65] Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma, P., Shah, H. H., et al. (2020). Acute kidney injury in patients hospitalized with COVID-19. Kidney International, 98(1), 209–218.
    Source: Kidney International
    DOI: 10.1016/j.kint.2020.05.006 Open PDF
    Already cited
70. [R137] Hofmann, H., Geier, M., Marzi, A., Krumbiegel, M., Peipp, M., et al. (2004). Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.
    Source: Biochemical and Biophysical Research Communications
    DOI: 10.1016/j.bbrc.2004.05.114
71. [R162] Hong, N. & Du, X. (2004). Avascular necrosis of bone in severe acute respiratory syndrome.
    Source: Clinical Radiology
    DOI: 10.1016/j.crad.2003.12.008 Open PDF
72. [R177] Hu, L., Fan, Z., Du, H., Ni, R., Zhang, S., et al. (2011). BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase.
    Source: Thrombosis and Haemostasis
    DOI: 10.1160/th11-06-0400
73. [R33] Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
    Source: The Lancet
    DOI: 10.1016/s0140-6736(20)30183-5 Open PDF
74. [R83] Huang, J., Shi, X., Xi, W., Liu, P., Long, Z., & Xi, X. (2015). Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy.
    Source: Journal of Hematology & Oncology
    DOI: 10.1186/s13045-015-0159-8 Open PDF
75. [R42] Jeong, Y. D., Ejima, K., Kim, K. S., Iwanami, S., Hart, W. S., et al. (2025). A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks.
    Source: Communications Medicine
    DOI: 10.1038/s43856-024-00716-3 Open PDF
76. [R129] Jin, H., Anderson, A. C., Tan, W. G., West, E. E., Ha, S., et al. (2010). Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Source: Proceedings of the National Academy of Sciences
    DOI: 10.1073/pnas.1009731107
77. [R99] Jin, H., Chen, L., Zhang, Z., Xu, Y., Song, B., et al. (2015). Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Source: Journal of Translational Medicine
    DOI: 10.1186/s12967-015-0616-8 Open PDF
78. [R30] Kai, H. & Kai, M. (2020). Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19. Hypertension Research, 43(7), 648–654.
    Source: Hypertension Research
    DOI: 10.1038/s41440-020-0455-8 Open PDF
    Already cited
79. [R192] Kauskot, A., Adam, F., Mazharian, A., Ajzenberg, N., Berrou, E., et al. (2007). Involvement of the Mitogen-activated Protein Kinase c-Jun NH2-terminal Kinase 1 in Thrombus Formation.
    Source: Journal of Biological Chemistry
    DOI: 10.1074/jbc.m701596200 Open PDF
80. [R113] Kellum, J. A. (2011). Impaired renal blood flow and the ‘spicy food’ hypothesis of acute kidney injury*.
    Source: Critical Care Medicine
    DOI: 10.1097/ccm.0b013e31820f70bb
81. [R8] Kellum, J. A., Till, J. W. O. V., & Mulligan, G. (2020). Targeting acute kidney injury in COVID-19. Nephrology Dialysis Transplantation, 35(10), 1652–1662.
    Source: Nephrology Dialysis Transplantation
    DOI: 10.1093/ndt/gfaa231 Open PDF
    Already cited
82. [R178] Khaitan, A. & Unutmaz, D. (2010). Revisiting Immune Exhaustion During HIV Infection.
    Source: Current HIV/AIDS Reports
    DOI: 10.1007/s11904-010-0066-0 Open PDF
83. [R153] Khwaja, A. (2012). KDIGO Clinical Practice Guidelines for Acute Kidney Injury.
    Source: Nephron Clinical Practice
    DOI: 10.1159/000339789
84. [R69] Kohli, U., Meinert, E., Chong, G., Tesher, M., & Jani, P. (2020). Fulminant myocarditis and atrial fibrillation in child with acute COVID-19. Journal of Electrocardiology, 73, 150–152.
    Source: Journal of Electrocardiology
    DOI: 10.1016/j.jelectrocard.2020.10.004
    Already cited
85. [R116] Koupenova, M., Vitseva, O., MacKay, C. R., Beaulieu, L. M., Benjamin, E. J., et al. (2014). Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.
    Source: Blood
    DOI: 10.1182/blood-2013-11-536003 Open PDF
86. [R183] Koyner, J. L. & Murray, P. (2009). Mechanical Ventilation and the Kidney.
    Source: Blood Purification
    DOI: 10.1159/000259585 Open PDF
87. [R66] Kumar, D., Mukherjee, A., Sharma, R. K., Menon, G. R., Sahu, D., et al. (2021). Clinical profile of hospitalized COVID-19 patients in first &amp; second wave of the pandemic. The Indian Journal of Medical Research, 153(5-6), 619–628.
    Source: The Indian Journal of Medical Research
    DOI: 10.4103/ijmr.ijmr_1628_21
    Already cited
88. [R150] Kumar, G., Jayanti, V., Johnson, M. K., Uchic, J. T., Thomas, S., et al. (2004). Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans.
    Source: Pharmaceutical Research
    DOI: 10.1023/b:pham.0000041457.64638.8d
89. [R154] Kwek, S., Chew, W. M., Ong, K., Ng, A. W., Lee, L., et al. (2006). Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge.
    Source: Journal of Psychosomatic Research
    DOI: 10.1016/j.jpsychores.2005.08.020
90. [R15] Lam, M. (2009). Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors. Archives of Internal Medicine, 169(22), 2142.
    Source: Archives of Internal Medicine
    DOI: 10.1001/archinternmed.2009.384
    Already cited
91. [R119] Lambert, S., Bouttier, M., Vassy, R., Seigneuret, M., Petrow‐Sadowski, C., et al. (2009). HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
    Source: Blood
    DOI: 10.1182/blood-2008-04-150342 Open PDF
92. [R90] Lee, A. M., Wong, J. G., McAlonan, G., Cheung, V., Cheung, C., et al. (2007). Stress and Psychological Distress among SARS Survivors 1 Year after the Outbreak.
    Source: The Canadian Journal of Psychiatry
    DOI: 10.1177/070674370705200405
93. [R1] Li, B., Deng, A., Li, K., Hu, Y., Li, Z., et al. (2022). Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nature Communications, 13(1), 460.
    Source: Nature Communications
    DOI: 10.1038/s41467-022-28089-y Open PDF
    Already cited
94. [R103] Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
    Source: Nature
    DOI: 10.1038/nature02145 Open PDF
95. [R39] Li, Y., Gozzi, N., & Perra, N. (2025). Estimating behavioural relaxation induced by COVID-19 vaccines in the first months of their rollout.
    Source: PLoS Computational Biology
    DOI: 10.1371/journal.pcbi.1013266
96. [R4] Li, Z., Wu, M., Yao, J., Guo, J., Liao, X., et al. (2020). Caution on Kidney Dysfunctions of COVID-19 Patients.
    DOI: 10.1101/2020.02.08.20021212 Open PDF
    Already cited
97. [R101] Liang, Y., Fu, Y., Qi, R., Wang, M., Yang, N., et al. (2015). Cartilage oligomeric matrix protein is a natural inhibitor of thrombin.
    Source: Blood
    DOI: 10.1182/blood-2015-01-621292 Open PDF
98. [R38] Lin, H., Jiang, R., Qin, R., Yao, B., Zeng, W., et al. (2025). Characterization of a SARS-CoV-2 infection model in golden hamsters with diabetes mellitus.
    Source: Virologica Sinica
    DOI: 10.1016/j.virs.2025.05.001
99. [R62] Liu, J., Li, S., Liu, J., Liang, B., Wang, X., et al. (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 55, 102763.
    Source: EBioMedicine
    DOI: 10.1016/j.ebiom.2020.102763 Open PDF
    Already cited
100. [R5] Liu, T., Zhang, J., Yang, Y., Ma, H., Li, Z., et al. (2020). The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019. EMBO Molecular Medicine, 12(7), e12421.
     Source: EMBO Molecular Medicine
     DOI: 10.15252/emmm.202012421 Open PDF
     Already cited
101. [R70] Liu, Y., Gao, W., Guo, W., Guo, Y., Shi, M., et al. (2020). Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19. Journal of Thrombosis and Thrombolysis, 50(4), 825–832.
     Source: Journal of Thrombosis and Thrombolysis
     DOI: 10.1007/s11239-020-02174-9 Open PDF
     Already cited
102. [R114] Magnan, A., Mege, J., Escallier, J. C., Brisse, J., Capo, C., et al. (1996). Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group.
     Source: American Journal of Respiratory and Critical Care Medicine
     DOI: 10.1164/ajrccm.153.4.8616577
103. [R23] Mahalingasivam, V., Su, G., Iwagami, M., Davids, M. R., Wetmore, J. B., & Nitsch, D. (2022). COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nature Reviews Nephrology, 18(8), 485–498.
     Source: Nature Reviews Nephrology
     DOI: 10.1038/s41581-022-00570-3 Open PDF
     Already cited
104. [R163] Maison, A. G., Charest, A. F., & Geerts, W. (2005). Anticoagulant Use in Patients with Chronic Renal Impairment.
     Source: American Journal of Cardiovascular Drugs
     DOI: 10.2165/00129784-200505050-00002
105. [R161] Manns, B., Doig, C. J., Lee, H., Dean, S., Tonelli, M., et al. (2003). Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery*.
     Source: Critical Care Medicine
     DOI: 10.1097/01.ccm.0000045182.90302.b3
106. [R79] Marc, G. P., Alvarez‐Paggi, D., & Polack, F. P. (2021). Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine. Journal of Clinical Investigation, 131(12).
     Source: Journal of Clinical Investigation
     DOI: 10.1172/jci150135 Open PDF
     Already cited
107. [R138] Martinez‐Outschoorn, U., Prisco, M. D., Ertel, A., Tsirigos, A., Lin, Z., et al. (2011). Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer.
     Source: Cell Cycle
     DOI: 10.4161/cc.10.8.15330
108. [R24] Martini, A. L., Carli, G., Kiferle, L., Piersanti, P., Palumbo, P., et al. (2022). Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. European Journal of Nuclear Medicine and Molecular Imaging, 50(1), 90–102.
     Source: European Journal of Nuclear Medicine and Molecular Imaging
     DOI: 10.1007/s00259-022-05942-2 Open PDF
     Already cited
109. [R64] Martínez-Rojas, M. A., Vega‐Vega, O., & Bobadilla, N. A. (2020). Is the kidney a target of SARS-CoV-2?. American Journal of Physiology-Renal Physiology, 318(6), F1454–F1462.
     Source: American Journal of Physiology-Renal Physiology
     DOI: 10.1152/ajprenal.00160.2020
     Already cited
110. [R53] Matyushin, N., Ermakov, D., Vasileva, I. N., Vakolyuk, R., & Spaska, A. (2023). Investigating kidney function changes in young adults with COVID-19: Serum creatinine level, glomerular filtration rate, and biochemical profile analysis.
     Source: Electronic Journal of General Medicine
     DOI: 10.29333/ejgm/13750 Open PDF
111. [R73] McGonagle, D., Sharif, Κ., O’Regan, A., & Bridgewood, C. (2020). The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity Reviews, 19(6), 102537.
     Source: Autoimmunity Reviews
     DOI: 10.1016/j.autrev.2020.102537
     Already cited
112. [R82] Mihaylova, I., DeRuyter, M., Rummens, J., Bosmans, E., & Maes, M. (2007). Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
     URL: https://pubmed.ncbi.nlm.nih.gov/17693977
113. [R68] Minami, T., Iwata, Y., & Wada, T. (2020). Renal complications in coronavirus disease 2019: a systematic review. Inflammation and Regeneration, 40(1), 31.
     Source: Inflammation and Regeneration
     DOI: 10.1186/s41232-020-00140-9 Open PDF
     Already cited
114. [R175] Miyakis, S., Lockshin, M. D., Atsumi, T., Branch, D. W., Brey, R. L., et al. (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
     Source: Journal of Thrombosis and Haemostasis
     DOI: 10.1111/j.1538-7836.2006.01753.x Open PDF
115. [R194] Mocroft, A., Kirk, O., Reiss, P., Wit, S. D., Sedláček, D., et al. (2010). Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
     Source: AIDS
     DOI: 10.1097/qad.0b013e328339fe53
116. [R109] Nicholls, J. M., Poon, L. L. M., Lee, K. C., Ng, W. F., Lai, S. T., et al. (2003). Lung pathology of fatal severe acute respiratory syndrome.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(03)13413-7 Open PDF
117. [R48] Palmer, M. E., Belcher, R. M., Engeleit, A., Wenzler, E., Bulman, Z. P., & Benken, S. (2023). Pharmacokinetics and dialytic clearance of baricitinib during in vivo continuous venovenous haemodialysis in a patient with COVID-19.
     Source: International Journal of Antimicrobial Agents
     DOI: 10.1016/j.ijantimicag.2023.106920
118. [R14] Peng, L., Liu, J., Xu, W., Luo, Q., Deng, K., et al. (2020). 2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples.
     DOI: 10.1101/2020.02.21.20026179 Open PDF
     Already cited
119. [R112] Perani, D., Rosa, P. A. D., Cerami, C., Gallivanone, F., Fallanca, F., et al. (2014). Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
     Source: NeuroImage Clinical
     DOI: 10.1016/j.nicl.2014.10.009
120. [R166] Poteser, M., Graziani, A., Rosker, C., Eder, P., Derler, I., et al. (2006). TRPC3 and TRPC4 Associate to Form a Redox-sensitive Cation Channel.
     Source: Journal of Biological Chemistry
     DOI: 10.1074/jbc.m512205200 Open PDF
121. [R25] Rabaan, A. A., Smajlović, S., Tombuloğlu, H., Ćordić, S., Hajdarević, A., et al. (2022). SARS‐CoV‐2 infection and multi-organ system damage: A review. Biomolecules and Biomedicine, 23(1), 37–52.
     Source: Biomolecules and Biomedicine
     DOI: 10.17305/bjbms.2022.7762
     Already cited
122. [R85] Raichle, M. E. (2023). Science.
     Source: Science
     DOI: 10.1126/science
123. [R20] Rana, R., Ranjan, V., Kumar, N., Chugh, P., Khillan, K., et al. (2022). Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study. Molecular and Cellular Biochemistry, 478(1), 149–160.
     Source: Molecular and Cellular Biochemistry
     DOI: 10.1007/s11010-022-04485-2 Open PDF
     Already cited
124. [R44] Rathinam, J., Gnanadhas, F., & Stephy, G. M. (2025). Eco-friendly Phycoremediation: Utilizing Algae for Effective Wastewater and Pollutant Management.
     Source: Water Air & Soil Pollution
     DOI: 10.1007/s11270-025-08304-4
125. [R141] Recalcati, S., Invernizzi, P., Arosio, P., & Cairo, G. (2008). New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity.
     Source: Journal of Autoimmunity
     DOI: 10.1016/j.jaut.2007.11.003
126. [R170] Rocha‐Pereira, J., Jochmans, D., Dallmeier, K., Leyssen, P., Nascimento, M. S. J., & Neyts, J. (2012). Favipiravir (T-705) inhibits in vitro norovirus replication.
     Source: Biochemical and Biophysical Research Communications
     DOI: 10.1016/j.bbrc.2012.07.034
127. [R189] Rondina, M. T., Brewster, B., Grissom, C. K., Zimmerman, G. A., Kastendieck, D., et al. (2012). In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1).
     Source: CHEST Journal
     DOI: 10.1378/chest.11-2860 Open PDF
128. [R130] Rosa, P. A. D., Cerami, C., Gallivanone, F., Prestia, A., Caroli, A., et al. (2014). A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia.
     Source: Neuroinformatics
     DOI: 10.1007/s12021-014-9235-4
129. [R185] Sahebkar, A., Chew, G. T., & Watts, G. F. (2014). New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
     Source: Expert Opinion on Pharmacotherapy
     DOI: 10.1517/14656566.2014.876992
130. [R191] Saklatvala, J., Rawlinson, L., Waller, R. J., Sarsfield, S. J., Lee, J. C., et al. (1996). Role for p38 Mitogen-activated Protein Kinase in Platelet Aggregation Caused by Collagen or a Thromboxane Analogue.
     Source: Journal of Biological Chemistry
     DOI: 10.1074/jbc.271.12.6586 Open PDF
131. [R182] Salmi, A., Ziola, B., Hovi, T., & Reunanen, M. (1982). Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients.
     Source: Neurology
     DOI: 10.1212/wnl.32.3.292
132. [R67] Santoriello, D., Khairallah, P., Bomback, A. S., Xu, K., Kudose, S., et al. (2020). Postmortem Kidney Pathology Findings in Patients with COVID-19. Journal of the American Society of Nephrology, 31(9), 2158–2167.
     Source: Journal of the American Society of Nephrology
     DOI: 10.1681/asn.2020050744
     Already cited
133. [R47] Santos, L. F. T. D., Barbeiro, H. V., Barbeiro, D. F., Souza, H. P. D., & Silva, F. P. D. (2023). Antimicrobial peptides and other potential biomarkers of critical illness in Sars-CoV-2 patients with acute kidney injury.
     DOI: 10.1101/2023.07.08.23292389 Open PDF
134. [R100] Schwartz, G. J., Haycock, G. B., Edelmann, C. M., & Spitzer, A. (1976). A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine.
     Source: PEDIATRICS
     DOI: 10.1542/peds.58.2.259
135. [R35] Sekar, P. K. C. & Veerabathiran, R. (2025). COVID-19 associated acute kidney injury.
     Source: Infectious Diseases & Immunity
     DOI: 10.1097/id9.0000000000000160
136. [R63] Serafim, A. D. P., Durães, R. S. S., Rocca, C. C. A., Gonçalves, P. D., Saffi, F., et al. (2021). Exploratory study on the psychological impact of COVID-19 on the general Brazilian population. PLoS ONE, 16(2), e0245868.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0245868
     Already cited
137. [R102] Sheng, B., Cheng, S. K., Lau, K. K., Li, H. L., & Chan, E. L. Y. (2004). The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases.
     Source: European Psychiatry
     DOI: 10.1016/j.eurpsy.2004.06.023 Open PDF
138. [R168] Shrive, A., Gheetham, G. M., Holden, D. W., Myles, D. A. A., Turnell, W. G., et al. (1996). Three dimensional structure of human C-reactive protein.
     Source: Nature Structural & Molecular Biology
     DOI: 10.1038/nsb0496-346
139. [R34] Shu, Y., Huang, J., Zhang, Y., Wang, F., Wang, X., et al. (2025). Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection.
     Source: BMC Nephrology
     DOI: 10.1186/s12882-025-04000-x Open PDF
140. [R54] Shu, Z. (2023). Kidney injury in COVID-19 patients: Clinical manifestations and pathogenesis.
     Source: Open Journal of Clinical and Medical Case Reports
     DOI: 10.52768/2379-1039/2033 Open PDF
141. [R159] Silvester, W. (1997). Mediator removal with CRRT: Complement and cytokines.
     Source: American Journal of Kidney Diseases
     DOI: 10.1016/s0272-6386(97)90541-2
142. [R87] Simon, A. Y., Sutherland, M. R., & Pryzdial, E. L. (2015). Dengue virus binding and replication by platelets.
     Source: Blood
     DOI: 10.1182/blood-2014-09-598029 Open PDF
143. [R160] Singbartl, K. & Kellum, J. A. (2011). AKI in the ICU: definition, epidemiology, risk stratification, and outcomes.
     Source: Kidney International
     DOI: 10.1038/ki.2011.339
144. [R120] Singbartl, K., Bishop, J., Wen, X., Murugan, R., Chandra, S., et al. (2011). Differential effects of kidney–lung cross-talk during acute kidney injury and bacterial pneumonia.
     Source: Kidney International
     DOI: 10.1038/ki.2011.201 Open PDF
145. [R117] Smits, S. L., Lang, A. D., Brand, J. M. A. V. D., Leijten, L., IJcken, W. F. J. V., et al. (2010). Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates.
     Source: PLoS Pathogens
     DOI: 10.1371/journal.ppat.1000756 Open PDF
146. [R123] Song, H., Tu, C., Zhang, G., Wang, S., Zheng, K., et al. (2005). Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.
     Source: Proceedings of the National Academy of Sciences
     DOI: 10.1073/pnas.0409608102
147. [R17] Sorkhi, H., Dooki, M. E., Nikpour, M., Mohammadi, M., Mohammadpour-Mir, A., et al. (2022). COVID-19 and renal involvement in children: a retrospective study. PubMed, 13(Suppl 3), 193–198.
     DOI: 10.22088/cjim.13.0.193
     Already cited
148. [R174] Stockman, L. J., Bellamy, R., & Garner, P. (2006). SARS: Systematic Review of Treatment Effects.
     Source: PLoS Medicine
     DOI: 10.1371/journal.pmed.0030343 Open PDF
149. [R6] Su, H., Yang, M., Wan, C., Yi, L., Tang, F., et al. (2020). Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International, 98(1), 219–227.
     Source: Kidney International
     DOI: 10.1016/j.kint.2020.04.003 Open PDF
     Already cited
150. [R71] Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., et al. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular and Molecular Immunology, 17(6), 613–620.
     Source: Cellular and Molecular Immunology
     DOI: 10.1038/s41423-020-0400-4 Open PDF
     Already cited
151. [R151] Takasu, O., Gaut, J. P., Watanabe, E., To, K., Fagley, R. E., et al. (2013). Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis.
     Source: American Journal of Respiratory and Critical Care Medicine
     DOI: 10.1164/rccm.201211-1983oc
152. [R195] Tanrıverdi, F., Karaca, Z., Ünlühızarcı, K., & Keleştimur, F. (2007). The hypothalamo–pituitary–adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
     Source: Stress
     DOI: 10.1080/10253890601130823 Open PDF
153. [R59] Teichmann, P. D. V., Moschetta, M. O., Franco, R. F., Vicari, A. R., Nunes, G. L. D. S., et al. (2022). One-year impact of COVID-19 pandemic on renal replacement therapy and kidney transplantation in a tertiary center in Southern Brazil. Brazilian Journal of Nephrology, 45(2), 210–217.
     Source: Brazilian Journal of Nephrology
     DOI: 10.1590/2175-8239-jbn-2022-0034en Open PDF
     Already cited
154. [R37] Tetteh, F. K., Degbe, F. D., Attah, J., Awumah, E. K., & Nyamekye, B. (2025). Clarifying supply chain social capital and operational excellence relationship from a social capital and contingency perspectives: evidence from small and medium-sized enterprises.
     Source: International Journal of Quality & Reliability Management
     DOI: 10.1108/ijqrm-07-2024-0228
155. [R21] Turabián, J. L. (2022). Covid-19 Breakthrough Infections In Vaccinated People With Vaccine Booster In 2022 Versus Covid-19 Cases In Unvaccinated People In 2020: A New Disease Whose Clinic we Should Know or Another Cause of The Old Symptoms of The Common Cold?. General medicine and Clinical Practice, 5(2), 01–07.
     Source: General medicine and Clinical Practice
     DOI: 10.31579/2639-4162/060 Open PDF
     Already cited
156. [R146] Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., et al. (2015). Tissue-based map of the human proteome.
     Source: Science
     DOI: 10.1126/science.1260419
157. [R89] Ulusoy, Ş., Arı, D., Özkan, G., Cansız, M., & Kaynar, K. (2015). The Frequency and Outcome of Acute Kidney Injury in a Tertiary Hospital: Which Factors Affect Mortality?.
     Source: Artificial Organs
     DOI: 10.1111/aor.12449
158. [R52] Utkina, E. V., Novakovskaya, V. V., Егорова, М. В., Фомина, Н. В., & Chesnokova, L. D. (2023). Mechanisms of renal damage in patients with new coronavirus infection (literature review).
     Source: Сибирский научный медицинский журнал
     DOI: 10.18699/ssmj20230401 Open PDF
159. [R56] Utkina, E. V., Novakovskaya, V. V., Егорова, М. В., Фомина, Н. В., & Chesnokova, L. D. (2024). Mechanisms of Kidney Damage Development in Patients with New Coronavirus Infection: Literature Review.
     Source: Cell and Tissue Biology
     DOI: 10.1134/s1990519x24700196
160. [R28] Vanmassenhove, J., Kielstein, J. T., Jörres, A., & Biesen, W. V. (2017). Management of patients at risk of acute kidney injury. The Lancet, 389(10084), 2139–2151.
     Source: The Lancet
     DOI: 10.1016/s0140-6736(17)31329-6
     Already cited
161. [R46] Vatazin, A. V., Golovina, E. N., Zulkarnaev, A. B., Stepanov, V. A., Fedulkina, V. A., & Artamonova, A. A. (2026). Risk factors for death and severity of the course of the new coronavirus infection (COVID-19).
     Source: Nephrology (Saint-Petersburg)
     DOI: 10.36485/1561-6274-2025-29-4-77-84
162. [R104] Velthuis, A. J. T. (2014). Common and unique features of viral RNA-dependent polymerases.
     Source: Cellular and Molecular Life Sciences
     DOI: 10.1007/s00018-014-1695-z Open PDF
163. [R176] Verhamme, P., Goossens, G., Maleux, G., Collen, D., & Stas, M. (2007). A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion.
     Source: Journal of Thrombosis and Thrombolysis
     DOI: 10.1007/s11239-006-0006-4
164. [R144] Vigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993). Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.
     Source: Journal of Clinical Investigation
     DOI: 10.1172/jci116336 Open PDF
165. [R22] Vornicu, A., Berechet, A., Frățilă, G., Obrișcă, B., Jurcuț, C., & Ismail, G. (2022). Relapse of cryoglobulinemic vasculitis with new-onset severe renal involvement in two patients following mRNA COVID-19 vaccination. Medicine, 101(23), e29431.
     Source: Medicine
     DOI: 10.1097/md.0000000000029431
     Already cited
166. [R127] Wakahara, S., Konoshita, T., Mizuno, S., Motomura, M., Aoyama, C., et al. (2007). Synergistic Expression of Angiotensin-Converting Enzyme (ACE) and ACE2 in Human Renal Tissue and Confounding Effects of Hypertension on the ACE to ACE2 Ratio.
     Source: Endocrinology
     DOI: 10.1210/en.2006-1287
167. [R147] Wang, H., Zhang, H., Zhang, J., Li, Y., Zhao, B., et al. (2015). Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.
     Source: Nature Communications
     DOI: 10.1038/ncomms7240 Open PDF
168. [R43] Wang, H., Zhou, W., Wang, X., Xiao, Y., Tang, S., & Tang, B. (2025). Modeling-based design of adaptive control strategy for the effective preparation of ‘Disease X’.
     Source: BMC Medical Informatics and Decision Making
     DOI: 10.1186/s12911-025-02920-0 Open PDF
169. [R3] Wang, L., Li, X., Chen, H., Yan, S., Dong, L., et al. (2020). Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. American Journal of Nephrology, 51(5), 343–348.
     Source: American Journal of Nephrology
     DOI: 10.1159/000507471 Open PDF
     Already cited
170. [R96] Wang, X., Shi, G. C., Wan, H., Hang, S. G., Chen, H., et al. (2013). Clinical features of three avian influenza <scp>H7N</scp>9 virus‐infected patients in <scp>S</scp>hanghai.
     Source: The Clinical Respiratory Journal
     DOI: 10.1111/crj.12087 Open PDF
171. [R121] Wang, Y., Lin, A., Chao, T., Lu, S., Liu, J., et al. (2004). A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan.
     Source: Intensive Care Medicine
     DOI: 10.1007/s00134-004-2311-8 Open PDF
172. [R142] Waugh, J. M. & Perry, C. M. (2005). Anakinra.
     Source: BioDrugs
     DOI: 10.2165/00063030-200519030-00005
173. [R78] Wilbers, T. & Koning, M. V. (2020). Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery and filter lifetime. Journal of Critical Care, 60, 103–105.
     Source: Journal of Critical Care
     DOI: 10.1016/j.jcrc.2020.07.025
     Already cited
174. [R26] Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995). Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle Cells. Hypertension, 25(5), 913–917.
     Source: Hypertension
     DOI: 10.1161/01.hyp.25.5.913
     Already cited
175. [R187] Wong, C. K., Lam, C., Wu, A., Ip, W., Lee, N., et al. (2004). Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.
     Source: Clinical & Experimental Immunology
     DOI: 10.1111/j.1365-2249.2004.02415.x Open PDF
176. [R148] Wu, K. & Chan, K. S. (2003). The development of the Chinese version of Impact of Event Scale - Revised (CIES-R).
     Source: Social Psychiatry and Psychiatric Epidemiology
     DOI: 10.1007/s00127-003-0611-x
177. [R145] Wu, K. K., Chan, S. K., & Tracy, M. (2005). Posttraumatic Stress after SARS.
     Source: Emerging infectious diseases
     DOI: 10.3201/eid1108.041083 Open PDF
178. [R13] Xia, S., Zhang, Y., Wang, Y., Wang, H., Yang, Y., et al. (2020). Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. The Lancet Infectious Diseases, 21(1), 39–51.
     Source: The Lancet Infectious Diseases
     DOI: 10.1016/s1473-3099(20)30831-8 Open PDF
     Already cited
179. [R31] Xu, J., Chu, M., Zhong, F., Tan, X., Tang, G., et al. (2020). Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs. Cell Death Discovery, 6(1), 76.
     Source: Cell Death Discovery
     DOI: 10.1038/s41420-020-00307-w Open PDF
     Already cited
180. [R156] Yang, B. (2003). Pharmacokinetics of anakinra in subjects with different levels of renal function.
     Source: Clinical Pharmacology & Therapeutics
     DOI: 10.1016/s0009-9236(03)00094-8
181. [R108] Yang, H., Adili, R., CHEN, P., Zhu, G., Hynes, R. O., et al. (2006). Fibrinogen and von Willebrand factor‐independent platelet aggregation in vitro and in vivo.
     Source: Journal of Thrombosis and Haemostasis
     DOI: 10.1111/j.1538-7836.2006.02116.x Open PDF
182. [R179] Yang, J., Lin, S., Ji, X., & Guo, L. (2009). Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.
     Source: Acta Diabetologica
     DOI: 10.1007/s00592-009-0109-4 Open PDF
183. [R107] Yang, Z., Werner, H., Kong, W., Leung, K., Traggiai, E., et al. (2005). Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.
     Source: Proceedings of the National Academy of Sciences
     DOI: 10.1073/pnas.0409065102
184. [R75] Yeung, M. L., Yao, Y., Jia, L., Chan, J. F., Chan, K., et al. (2016). MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nature Microbiology, 1(3), 16004.
     Source: Nature Microbiology
     DOI: 10.1038/nmicrobiol.2016.4 Open PDF
     Already cited
185. [R41] Yin, K., Wang, Y., & Meng, X. (2025). The evolutionary battle: data-driven analysis of SARS-CoV-2 virulence.
     Source: Computer Methods in Biomechanics & Biomedical Engineering
     DOI: 10.1080/10255842.2025.2582765
186. [R165] Yiu, H., Graham, A. L., & Stengel, R. F. (2012). Dynamics of a Cytokine Storm.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0045027 Open PDF
187. [R55] Zacchetti, L., Brivio, M., Mezzapesa, M., Martinelli, A., Punzi, V., et al. (2024). The Effect of Positive Pressure Ventilation on Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: An Observational Study.
     Source: Blood Purification
     DOI: 10.1159/000536285
188. [R9] Zhang, S., Liu, Y., Wang, X., Li, Y., Li, H., et al. (2020). SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Journal of Hematology & Oncology, 13(1), 120.
     Source: Journal of Hematology & Oncology
     DOI: 10.1186/s13045-020-00954-7 Open PDF
     Already cited
189. [R134] Zhang, S., Zhang, S., Hu, L., Zhai, L., Xue, R., et al. (2015). Nucleotide-Binding Oligomerization Domain 2 Receptor Is Expressed in Platelets and Enhances Platelet Activation and Thrombosis.
     Source: Circulation
     DOI: 10.1161/circulationaha.114.013743
190. [R105] Zhang, T., Chen, H., Liang, S., Chen, D., Zheng, C., et al. (2014). A Non-Invasive Laboratory Panel as a Diagnostic and Prognostic Biomarker for Thrombotic Microangiopathy: Development and Application in a Chinese Cohort Study.
     Source: PLoS ONE
     DOI: 10.1371/journal.pone.0111992 Open PDF
191. [R95] Zhang, X., Wang, Q., Zhang, J., Feng, F., Wang, F., et al. (2015). Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.
     Source: Journal of Hematology & Oncology
     DOI: 10.1186/s13045-015-0216-3 Open PDF
192. [R193] Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S., Fett, C., et al. (2014). Rapid generation of a mouse model for Middle East respiratory syndrome.
     Source: Proceedings of the National Academy of Sciences
     DOI: 10.1073/pnas.1323279111 Open PDF
193. [R10] Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., et al. (2020). Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. National Science Review, 7(6), 998–1002.
     Source: National Science Review
     DOI: 10.1093/nsr/nwaa041 Open PDF
     Already cited
194. [R80] Ünver, S., Haholu, A., & Yıldırım, Ş. (2021). Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine. Clinical Kidney Journal, 14(12), 2608–2611.
     Source: Clinical Kidney Journal
     DOI: 10.1093/ckj/sfab155 Open PDF
     Already cited
195. [R36] Бердников, Г. А., Rey, S. I., Сагиров, М. А., Selyaev, V. S., Kovalev, A. I., & Косолапов, Д. А. (2024). Acute Kidney Injury in Patients with Novel Coronavirus Infection COVID-19 After Cardiac Surgery.
     Source: Russian Sklifosovsky Journal Emergency Medical Care
     DOI: 10.23934/2223-9022-2024-13-2-186-195 Open PDF
196. [R18] Перепелица, С. А. (2022). Diagnostics of macrophage activation syndrome, depending on IL-6 initial level in patients with a novel coronavirus infection. Russian Journal of Infection and Immunity, 12(4), 677–687.
     Source: Russian Journal of Infection and Immunity
     DOI: 10.15789/2220-7619-dom-1905 Open PDF
     Already cited